1
/
of
1
Elabscience
SKU:PKSV030314
Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His)(Active)
Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His)(Active)
Regular price
$380.00 USD
Regular price
Sale price
$380.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His)(Active), a cutting-edge product meticulously developed to address the urgent need for effective solutions in combating the ongoing global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
This protein, derived through recombinant technology, exhibits exceptional stability and trimeric structure, rendering it an invaluable tool for various research applications. With its active properties, it serves as a reliable resource for scientists and researchers seeking to unravel the intricate mechanisms of SARS-CoV-2 infection and develop potential therapeutic interventions.
The Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His)(Active) boasts a high level of purity, ensuring optimal experimental outcomes and accurate data interpretation. Its production adheres to stringent quality control measures, guaranteeing consistency and reliability in every batch.
This protein is designed to facilitate comprehensive investigations into the viral spike protein, a crucial component responsible for viral entry into host cells. By utilizing this advanced tool, researchers can gain deeper insights into the viral pathogenesis, host immune response, and potential targets for vaccine development.
Furthermore, the inclusion of a C-terminal 6-His tag enhances the protein's versatility, enabling facile purification and subsequent downstream applications. This feature streamlines experimental workflows, saving valuable time and resources.
The Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His)(Active) is meticulously manufactured in state-of-the-art facilities, employing cutting-edge techniques and adhering to rigorous quality standards. Each vial is meticulously packaged to ensure product integrity during transit and storage.
In summary, the Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His)(Active) stands as a paramount asset in the pursuit of understanding and combating the SARS-CoV-2 virus. Its exceptional stability, trimeric structure, and active properties make it an indispensable tool for researchers and scientists dedicated to unraveling the mysteries of this global health crisis.
This protein, derived through recombinant technology, exhibits exceptional stability and trimeric structure, rendering it an invaluable tool for various research applications. With its active properties, it serves as a reliable resource for scientists and researchers seeking to unravel the intricate mechanisms of SARS-CoV-2 infection and develop potential therapeutic interventions.
The Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His)(Active) boasts a high level of purity, ensuring optimal experimental outcomes and accurate data interpretation. Its production adheres to stringent quality control measures, guaranteeing consistency and reliability in every batch.
This protein is designed to facilitate comprehensive investigations into the viral spike protein, a crucial component responsible for viral entry into host cells. By utilizing this advanced tool, researchers can gain deeper insights into the viral pathogenesis, host immune response, and potential targets for vaccine development.
Furthermore, the inclusion of a C-terminal 6-His tag enhances the protein's versatility, enabling facile purification and subsequent downstream applications. This feature streamlines experimental workflows, saving valuable time and resources.
The Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His)(Active) is meticulously manufactured in state-of-the-art facilities, employing cutting-edge techniques and adhering to rigorous quality standards. Each vial is meticulously packaged to ensure product integrity during transit and storage.
In summary, the Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His)(Active) stands as a paramount asset in the pursuit of understanding and combating the SARS-CoV-2 virus. Its exceptional stability, trimeric structure, and active properties make it an indispensable tool for researchers and scientists dedicated to unraveling the mysteries of this global health crisis.
Share
